iBio IBIO
NASDAQ IBIO
$1.12 -0.06 (-5.08%)
As of: Oct 1, 2026 · 3:27 PM EDT

iBio (IBIO) Other Non-Current Assets (2011 - 2026)

Updated

iBio (IBIO) reported Other Non-Current Assets of $228,000 for fiscal Q4 2026 (quarter ended Jun 30, 2026), up 8.6% from $210,000 a year earlier but down 19.1% from the prior quarter.

Analysis

iBio (IBIO) Other Non-Current Assets (2011 - 2026) Analysis & Trends

Dating back to fiscal Q2 2012, iBio's Other Non-Current Assets record includes 43 quarters.

  • Other Non-Current Assets has a five-year compound annual growth rate of 56.9% (FY2021 to FY2026).
  • By fiscal year, Other Non-Current Assets came in at $210,000 in FY2025 (-2.3%), $215,000 in FY2024 (-15.0%), $253,000 in FY2023 (-99.3%) and $37.31 million in FY2022.
  • Five-year quarterly Other Non-Current Assets spans a low of $210,000 in fiscal Q4 2025 and a high of $37.31 million in fiscal Q4 2022.
  • Year over year, Other Non-Current Assets has now increased in each of the last four quarters, with an average decline of 27.3% over the last eight quarters.
  • The high point for year-over-year Other Non-Current Assets in five years was fiscal Q1 2023 (growth of 362.7%); the low point was fiscal Q4 2023 (a decline of 99.3%).
  • Per Business Quant data, the three fiscal quarters before Q4 2026 came in at $282,000 (Q3 2026), $228,000 (Q2 2026) and $228,000 (Q1 2026).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Other Non-Current Assets (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn 14.27 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn 10.73 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn 19.60 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn 5.93 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn -
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn 12.98 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn 4.75 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn 9.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn 1.25 Bn
10 iBio 122.79 Mn 122.79 Mn - 228,000.00
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 228,000.00
Mar 31, 2026 282,000.00
Dec 31, 2025 228,000.00
Sep 30, 2025 228,000.00
Jun 30, 2025 210,000.00
Mar 31, 2025 223,000.00
Dec 31, 2024 223,000.00
Sep 30, 2024 223,000.00
Jun 30, 2024 215,000.00
Mar 31, 2024 1.10 Mn
Dec 31, 2023 1.30 Mn
Sep 30, 2023 3.30 Mn
Jun 30, 2023 253,000.00
Mar 31, 2023 3.30 Mn
Dec 31, 2022 300,000.00
Sep 30, 2022 6.00 Mn
Jun 30, 2022 37.31 Mn
Mar 31, 2022 5.94 Mn
Dec 31, 2021 5.94 Mn
Sep 30, 2021 1.30 Mn
API Access

iBio Other Non-Current Assets API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-assets&ticker=IBIO&period=max&api_key=YOUR_API_KEY